These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18695386)

  • 1. Does dosing antihypertensive drugs at night alter renal or cardiovascular outcome: do we have the evidence?
    Stergiou GS; Nasothimiou EG
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):464-9. PubMed ID: 18695386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation of blood pressure and the assessment of antihypertensive therapy.
    White WB
    Blood Press Monit; 1999; 4 Suppl 1():S3-6. PubMed ID: 10822410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study.
    Portaluppi F; Smolensky MH
    Chronobiol Int; 2010 Sep; 27(8):1652-67. PubMed ID: 20854140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotherapy in hypertensive patients: administration-time dependent effects of treatment on blood pressure regulation.
    Hermida RC; Ayala DE; Smolensky MH; Portaluppi F
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):463-75. PubMed ID: 17489671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
    Guzik P; Wykretowicz A; Krauze T; Piskorski J; Adamska K; Milewska A; Wesseling KH; Wysocki H
    Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of aggressive blood pressure lowering when it may matter most.
    White WB
    Am J Cardiol; 2007 Aug; 100(3A):10J-16J. PubMed ID: 17666192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure.
    Hermida RC; Ayala DE; Calvo C; Portaluppi F; Smolensky MH
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):923-39. PubMed ID: 17659803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical chronopharmacology of the cardiovascular system: hypertension and coronary heart disease.
    Lemmer B
    Clin Ter; 2006; 157(1):41-52. PubMed ID: 16669551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronobiology of blood pressure and chronopharmacotherapy of arterial hypertension].
    Schmieder RE; Bramlage P; Schunkert H
    Dtsch Med Wochenschr; 2012 Feb; 137(7):317-21. PubMed ID: 22318846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evening -versus morning- dosing drug therapy for chronic kidney disease patients with hypertension: a systematic review.
    Liu X; Liu X; Huang W; Leo S; Li Y; Liu M; Yuan H
    Kidney Blood Press Res; 2014; 39(5):427-40. PubMed ID: 25471279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial blood pressure circadian rhythm: significance and clinical implications].
    Gonzalez Rodriguez E; Hernandez A; Dibner C; Koehler Ballan B; Pechère-Bertschi A
    Rev Med Suisse; 2012 Sep; 8(353):1709-12, 1714-5. PubMed ID: 23029984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics.
    White WB
    Blood Press Monit; 1997 Dec; 2(1):47-51. PubMed ID: 10234091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hour blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugs.
    Elliott HL
    J Hum Hypertens; 2004 Aug; 18(8):539-43. PubMed ID: 15190262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in dialysis patients: do some antihypertensive drugs have specific antioxidant effects or is it just blood pressure reduction? Does antioxidant treatment reduce the risk for cardiovascular disease?
    Aslam S
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):99-105. PubMed ID: 18090678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacology and its impact on antihypertensive treatment.
    Lemmer B
    Acta Physiol Pharmacol Bulg; 1999; 24(3):71-80. PubMed ID: 10736610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension.
    Schillaci G; Battista F; Settimi L; Schillaci L; Pucci G
    Curr Pharm Des; 2015; 21(6):756-72. PubMed ID: 25341857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masked hypertension: subtypes and target organ damage.
    Kawano Y; Horio T; Matayoshi T; Kamide K
    Clin Exp Hypertens; 2008 Apr; 30(3):289-96. PubMed ID: 18425708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian regulation of renal function and potential role in hypertension.
    Bonny O; Firsov D
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):439-44. PubMed ID: 23666414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.